Treace Medical Concepts, Inc. (TMCI) — Analyst outlook / Analyst consensus target is. Based on 9 analyst ratings, the consensus is bullish — 2 Buy, 6 Hold, 1 Sell.
The consensus price target is $3.00, representing an upside of 34.5% from the current price $2.23.
Analysts estimate Earnings Per Share (EPS) of $-0.93 and revenue of $0.21B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.90 vs est $-0.93 (beat +2.9%). 2025: actual $-0.93 vs est $-0.94 (beat +0.9%). Analyst accuracy: 98%.
TMCI Stock — 12-Month Price Forecast
$3.00
▲ +34.53% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for Treace Medical Concepts, Inc., the price target is $3.00.
The average price target represents a +34.53% change from the last price of $2.23.
TMCI Analyst Ratings
Hold
Based on 9 analysts giving stock ratings to Treace Medical Concepts, Inc. in the past 3 months
EPS Estimates — TMCI
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.90
vs Est –$0.93
▲ 3.0% off
2025
Actual –$0.93
vs Est –$0.94
▲ 0.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — TMCI
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.209B
vs Est $0.208B
▲ 0.8% off
2025
Actual $0.213B
vs Est $0.212B
▲ 0.3% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
